Almost simultaneously, Nauck et al demonstrated that infusions of GLP-1 during slightly hyperglycemic clamp conditions in both patients with type 2 diabetes and matched controls elicited almost similar insulin responses (whereas GIP infusions were ineffective) (73). The gene discussed is INS; the disease is type 2 diabetes mellitus.